When NHE8 was knocked out in colon cancer cells by the CRISPR/Cas9 system and injected into mice, the tumors formed in mice were larger than those formed by wild-type tumor cells injected into mice, suggesting that NHE8 can inhibit the proliferation of cancer cells. This evidence concerns the gene SLC9A8 and malignant colon neoplasm.